Related Experiment Video
Updated: Jul 26, 2026

08:03
Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Glucose uptake in the chronically dysfunctional but viable myocardium
M Mäki1, M Luotolahti, P Nuutila
1Department of Clinical Physiology, University of Turku, Finland.
Circulation
|May 1, 1996
Summary
Insulin significantly increases glucose uptake in chronically dysfunctional but viable heart muscle in humans. This finding supports metabolic interventions for heart conditions with preserved insulin sensitivity.
Area of Science:
- Cardiology
- Nuclear Medicine
- Metabolic Research
Background:
- Human studies on glucose uptake regulation in dysfunctional but viable myocardium are lacking.
- Chronic myocardial dysfunction can result from occluded coronary arteries.
Purpose of the Study:
- To investigate glucose uptake regulation in chronically dysfunctional but viable human myocardium.
- To determine the effect of insulin on myocardial glucose uptake in these specific conditions.
Main Methods:
- Positron emission tomography (PET) with 2-fluoro-2-deoxy-D-glucose (FDG) was used to measure glucose uptake.
- Hyperinsulinemic euglycemic clamping assessed insulin's effect on glucose uptake.
- Myocardial blood flow was measured using oxygen-15-labeled water (H2O).
Main Results:
- Dysfunctional myocardium showed slightly reduced blood flow but increased glucose uptake in a fasting state.
- Insulin clamping induced a significant increase in glucose uptake in both dysfunctional and normal myocardial regions.
- Revascularization in patients confirmed tissue viability and subsequent wall-motion recovery.
Conclusions:
- Insulin-mediated glucose uptake is preserved in chronically dysfunctional but viable myocardium.
- These findings provide a basis for using metabolic interventions in patients with such myocardial conditions.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

